| 标题 |
Primary Prevention ICD Benefit Stratified by SGLT2 Inhibitor Therapy in Patients With HFrEF: Post Hoc Analysis of the EMPEROR-Reduced Trial |
| 网址 | |
| DOI |
10.1016/j.jchf.2026.06.019
doi
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)